— Know what they know.
Not Investment Advice

PACB NASDAQ

Pacific Biosciences of California, Inc.
1W: +3.3% 1M: -26.9% 3M: -22.4% YTD: -32.1% 1Y: +22.6% 3Y: -89.8% 5Y: -94.7%
$1.22
-0.03 (-2.40%)
 
Weekly Expected Move ±12.1%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 29 · $378.9M mcap · 302M float · 1.99% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
35.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -26.5%  ·  5Y Avg: -58.8%
Cost Advantage
21
Intangibles
48
Switching Cost
26
Network Effect
53
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PACB has No discernible competitive edge (35.9/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. Negative ROIC of -26.5% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$1
Avg Target
$1
High
Based on 3 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 9Hold: 8Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$1.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-14 Barclays $2 $1 -0 -31.0% $1.45
2025-08-08 Bernstein Eve Burstein Initiated $2 +27.3% $1.33
2025-06-25 Barclays Luke Sergott $2 $2 -0 +23.0% $1.22
2024-06-02 Jefferies Tycho Peterson Initiated $4 +123.5% $1.79
2024-05-13 Morgan Stanley Tejas Savant Initiated $4 +102.5% $1.98
2024-05-13 Piper Sandler David Westenberg $8 $2 -6 +13.0% $1.77
2024-05-10 Barclays Luke Sergott Initiated $2 +16.3% $1.72
2024-04-18 Goldman Sachs Matthew Sykes Initiated $2 +78.6% $1.40
2024-04-16 Canaccord Genuity Kyle Mikson $14 $4 -10 +150.0% $1.40
2022-11-16 Canaccord Genuity Initiated $14 +29.6% $10.80
2022-08-17 Piper Sandler David Westenberg $6 $8 +2 -1.4% $7.61
2022-05-15 Piper Sandler David Westenberg $20 $6 -14 +2.7% $5.84
2022-01-11 Piper Sandler David Westenberg Initiated $20 +38.4% $14.45

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PACB receives an overall rating of C. Strongest factors: DCF (5/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

25 Grade D
Profitability
10
Balance Sheet
0
Earnings Quality
57
Growth
72
Value
23
Momentum
68
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PACB scores highest in Growth (72/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.46
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
-3.15
Unlikely Manipulator
Ohlson O-Score
-3.65
Bankruptcy prob: 2.5%
Low Risk
Credit Rating
B-
Score: 21.6/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.87x
Accruals: -1.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PACB scores -4.46, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PACB scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PACB's score of -3.15 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PACB's implied 2.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PACB receives an estimated rating of B- (score: 21.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.90x
PEG
-0.03x
P/S
2.37x
P/B
157.69x
P/FCF
-3.47x
P/OCF
EV/EBITDA
-6.04x
EV/Revenue
5.52x
EV/EBIT
-5.69x
EV/FCF
-7.60x
Earnings Yield
-31.85%
FCF Yield
-28.79%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PACB currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.006
NI / EBT
×
Interest Burden
0.823
EBT / EBIT
×
EBIT Margin
-0.971
EBIT / Rev
×
Asset Turnover
0.157
Rev / Assets
×
Equity Multiplier
3.994
Assets / Equity
=
ROE
-50.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PACB's ROE of -50.2% is driven by financial leverage (equity multiplier: 3.99x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.22
Median 1Y
$0.64
5th Pctile
$0.15
95th Pctile
$2.82
Ann. Volatility
89.5%
Analyst Target
$1.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Christian O. Henry
President and Chief Executive Officer
$748,250 $1,151,013 $4,309,846
Jim R. Gibson
$376,923 $1,180,000 $3,493,189
Mark Van Oene
Chief Operating Officer
$620,125 $561,470 $2,366,113

CEO Pay Ratio

15:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $4,309,846
Avg Employee Cost (SGA/emp): $291,738
Employees: 485

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
485
-15.7% YoY
Revenue / Employee
$329,907
Rev: $160,005,000
Profit / Employee
$-1,126,548
NI: $-546,376,000
SGA / Employee
$291,738
Avg labor cost proxy
R&D / Employee
$200,633
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -39.6% -18.9% -32.2% -31.1% -36.5% -53.1% -46.4% -47.4% -47.2% -45.7% -48.5% -47.0% -63.3% -62.4% -51.3% -1.1% -87.2% -83.4% -2.1% -50.2% -50.23%
ROA -27.5% -13.2% -15.0% -14.5% -17.0% -24.7% -16.7% -17.0% -16.9% -16.4% -17.5% -16.9% -22.8% -22.4% -20.6% -43.8% -35.0% -33.5% -53.4% -12.6% -12.58%
ROIC -1.6% -2.3% -23.7% -28.6% -32.0% -32.1% -32.8% -34.3% -34.9% -35.7% -26.3% -25.5% -33.6% -32.2% -47.5% -82.3% -69.2% -66.6% -90.1% -26.5% -26.50%
ROCE -19.2% -32.7% -13.6% -13.2% -14.7% -14.7% -19.9% -20.3% -20.2% -20.3% -18.4% -17.8% -24.1% -23.1% -24.8% -54.1% -43.3% -41.7% -74.3% -21.3% -21.29%
Gross Margin 44.9% 44.0% 46.5% 42.7% 45.7% 41.9% 18.8% 25.1% 32.7% 32.1% 16.4% 29.1% 16.5% 25.0% 25.6% -3.7% 36.9% 39.2% 37.5% 34.5% 34.54%
Operating Margin -1.2% -2.1% -1.8% -2.3% -1.9% -2.3% -3.2% -2.3% -1.5% -1.5% -1.5% -2.1% -4.9% -1.6% -3.9% -11.5% -1.1% -1.0% -92.3% -1.0% -1.02%
Net Margin -1.3% 47.4% -1.9% -2.5% -2.0% -2.4% -3.1% -2.3% -1.5% -1.2% -1.4% -2.0% -4.8% -1.5% 6.0% -11.5% -1.1% -98.9% -90.4% -22.3% -22.26%
EBITDA Margin -1.1% -2.1% -1.7% -2.2% -1.8% -2.1% -2.8% -2.1% -1.3% -1.2% -1.1% -1.6% -4.3% -1.0% 41.8% -1.4% -89.5% -89.5% -86.1% -1.0% -1.02%
FCF Margin -69.4% -79.7% -89.7% -1.3% -1.6% -1.8% -2.2% -2.2% -1.9% -1.7% -1.4% -1.3% -1.4% -1.4% -1.4% -1.2% -1.0% -84.9% -74.3% -72.6% -72.62%
OCF Margin -67.0% -77.1% -85.2% -1.2% -1.5% -1.7% -2.1% -2.1% -1.8% -1.6% -1.3% -1.2% -1.3% -1.3% -1.3% -1.1% -95.8% -79.4% -69.5% -69.9% -69.89%
ROE 3Y Avg snapshot only -8.59%
ROE 5Y Avg snapshot only -5.31%
ROA 3Y Avg snapshot only -28.53%
ROIC 3Y Avg snapshot only -44.95%
ROIC Economic snapshot only -16.88%
Cash ROA snapshot only -14.26%
Cash ROIC snapshot only -23.05%
CROIC snapshot only -23.95%
NOPAT Margin snapshot only -80.36%
Pretax Margin snapshot only -79.84%
R&D / Revenue snapshot only 54.90%
SGA / Revenue snapshot only 82.78%
SBC / Revenue snapshot only 5.99%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -89.94 -148.72 -24.92 -11.54 -4.82 -4.37 -5.89 -8.74 -10.42 -6.89 -8.54 -3.40 -0.93 -1.18 -1.81 -0.53 -0.71 -0.76 -1.03 -3.14 -2.902
P/S Ratio 65.62 45.19 34.60 15.02 7.11 9.55 14.42 20.91 22.76 12.56 13.07 5.04 1.98 2.68 3.65 2.30 2.38 2.49 3.53 2.52 2.368
P/B Ratio 20.70 16.38 5.71 2.56 1.25 1.65 3.29 4.98 5.91 3.78 3.74 1.44 0.53 0.66 1.11 0.69 0.73 0.76 105.55 75.47 157.692
P/FCF -94.53 -56.73 -38.56 -11.48 -4.44 -5.25 -6.61 -9.47 -11.79 -7.58 -9.53 -3.95 -1.43 -1.94 -2.65 -1.91 -2.37 -2.93 -4.75 -3.47 -3.474
P/OCF
EV/EBITDA -106.76 -46.15 -17.64 -8.01 -3.35 -4.57 -7.19 -10.34 -12.24 -8.07 -10.78 -5.17 -1.94 -2.39 -3.48 -2.73 -5.84 -6.33 -6.52 -6.04 -6.038
EV/Revenue 63.00 42.91 33.92 14.36 6.47 8.90 15.80 22.23 23.96 13.60 14.58 6.55 3.58 4.43 5.48 4.15 4.19 4.32 6.53 5.52 5.522
EV/EBIT -92.72 -42.45 -16.86 -7.59 -3.17 -4.29 -6.77 -9.74 -11.51 -7.56 -9.62 -4.47 -1.70 -2.01 -2.85 -0.98 -1.27 -1.34 -1.93 -5.69 -5.689
EV/FCF -90.76 -53.87 -37.80 -10.97 -4.04 -4.89 -7.24 -10.07 -12.41 -8.21 -10.63 -5.13 -2.59 -3.20 -3.98 -3.46 -4.16 -5.09 -8.78 -7.60 -7.604
Earnings Yield -1.1% -0.7% -4.0% -8.7% -20.7% -22.9% -17.0% -11.4% -9.6% -14.5% -11.7% -29.4% -1.1% -85.0% -55.2% -1.9% -1.4% -1.3% -96.8% -31.9% -31.85%
FCF Yield -1.1% -1.8% -2.6% -8.7% -22.5% -19.0% -15.1% -10.6% -8.5% -13.2% -10.5% -25.3% -69.9% -51.6% -37.8% -52.3% -42.3% -34.1% -21.1% -28.8% -28.79%
EV/Gross Profit snapshot only 14.891
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 9.24 9.24 15.36 15.36 15.36 15.36 3.24 3.24 3.24 3.24 7.81 7.81 7.81 7.81 7.48 7.48 7.48 7.48 6.89 6.89 6.892
Quick Ratio 8.87 8.87 15.01 15.01 15.01 15.01 3.04 3.04 3.04 3.04 7.21 7.21 7.21 7.21 6.59 6.59 6.59 6.59 5.99 5.99 5.986
Debt/Equity 0.13 0.13 1.21 1.21 1.21 1.21 1.68 1.68 1.68 1.68 1.33 1.33 1.33 1.33 1.33 1.33 1.33 1.33 141.98 141.98 141.982
Net Debt/Equity -0.83 -0.83 -0.11 -0.11 -0.11 -0.11 0.31 0.31 0.31 0.31 0.43 0.43 0.43 0.43 0.56 0.56 0.56 0.56 89.73 89.73 89.728
Debt/Assets 0.10 0.10 0.48 0.48 0.48 0.48 0.54 0.54 0.54 0.54 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.97 0.97 0.969
Debt/EBITDA -0.67 -0.37 -3.81 -3.96 -3.54 -3.58 -3.36 -3.29 -3.32 -3.32 -3.44 -3.68 -2.68 -2.91 -2.77 -2.90 -6.00 -6.38 -4.74 -5.19 -5.190
Net Debt/EBITDA 4.43 2.45 0.35 0.37 0.33 0.33 -0.62 -0.61 -0.62 -0.62 -1.12 -1.19 -0.87 -0.94 -1.16 -1.22 -2.52 -2.68 -2.99 -3.28 -3.280
Interest Coverage -13.37 -13.59 -20.96 -17.65 -19.63 -19.54 -20.38 -20.91 -20.99 -21.15 -21.18 -20.58 -27.85 -26.76 -22.08 -55.83 -52.87 -62.50 -77.95 -44.67 -44.670
Equity Multiplier 1.23 1.23 2.54 2.54 2.54 2.54 3.14 3.14 3.14 3.14 2.49 2.49 2.49 2.49 2.49 2.49 2.49 2.49 146.58 146.58 146.585
Cash Ratio snapshot only 5.136
Debt Service Coverage snapshot only -42.087
Cash to Debt snapshot only 0.368
FCF to Debt snapshot only -0.153
Defensive Interval snapshot only 517.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.38 0.43 0.11 0.11 0.12 0.11 0.07 0.07 0.08 0.09 0.11 0.11 0.11 0.10 0.10 0.10 0.10 0.10 0.16 0.16 0.157
Inventory Turnover 4.40 4.95 3.69 3.85 3.97 3.93 2.11 2.38 2.72 3.23 2.76 2.73 2.69 2.55 2.02 2.21 2.13 2.01 2.13 1.86 1.864
Receivables Turnover 6.59 7.58 6.35 6.56 6.79 6.67 5.96 6.23 6.79 7.88 7.24 7.24 6.82 6.25 4.80 4.75 4.87 4.82 5.08 5.08 5.083
Payables Turnover 10.15 11.41 9.83 10.24 10.57 10.47 6.88 7.76 8.87 10.52 10.91 10.79 10.64 10.07 7.38 8.07 7.76 7.34 6.15 5.39 5.390
DSO 55 48 57 56 54 55 61 59 54 46 50 50 54 58 76 77 75 76 72 72 71.8 days
DIO 83 74 99 95 92 93 173 153 134 113 132 134 136 143 180 165 172 181 172 196 195.8 days
DPO 36 32 37 36 35 35 53 47 41 35 33 34 34 36 49 45 47 50 59 68 67.7 days
Cash Conversion Cycle 102 90 119 115 111 113 181 165 147 125 149 150 155 165 207 197 200 207 184 200 199.9 days
Fixed Asset Turnover snapshot only 2.431
Operating Cycle snapshot only 267.6 days
Cash Velocity snapshot only 0.573
Capital Intensity snapshot only 4.900
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 28.2% 52.6% 65.4% 45.9% 31.9% 12.6% -1.7% -0.5% 4.7% 23.8% 56.3% 49.5% 29.2% 2.1% -23.2% -24.0% -17.3% -10.7% 3.9% 5.0% 5.04%
Net Income -51.3% 19.0% -7.2% -2.0% -1.7% -7.1% -73.4% -83.0% -55.2% -3.3% 2.4% 7.4% -25.4% -27.5% -1.0% -1.2% -31.5% -27.7% -76.3% 80.5% 80.45%
EPS -17.5% 37.2% -6.7% -1.6% -1.4% -6.7% -69.2% -68.1% -39.3% 8.8% 17.3% 16.9% -15.2% -19.2% 12.1% -1.0% -19.3% -15.9% -79.2% 81.0% 81.02%
FCF -6.0% -7.7% -7.3% -1.2% -2.0% -1.6% -1.4% -67.9% -26.2% -12.8% 1.9% 13.5% 7.5% 14.7% 22.8% 28.5% 39.7% 45.2% 44.0% 36.5% 36.54%
EBITDA -57.2% -2.2% -7.4% -4.0% -3.3% -1.4% -12.4% -19.4% -5.9% -7.0% 3.9% 11.9% -21.6% -12.2% 10.5% 8.6% 67.8% 67.1% 34.0% 36.9% 36.94%
Op. Income -16.8% -72.6% -1.0% -1.4% -1.4% -67.8% -46.0% -26.2% -14.6% -17.3% -8.9% -1.1% -31.0% -22.4% -41.8% -1.5% -61.7% -62.8% -16.8% 80.2% 80.19%
OCF Growth snapshot only 35.88%
Asset Growth snapshot only -37.79%
Equity Growth snapshot only -98.94%
Debt Growth snapshot only 12.94%
Shares Change snapshot only 3.02%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 5.8% 13.1% 18.4% 21.2% 21.0% 18.4% 12.2% 14.2% 21.0% 28.6% 36.5% 29.5% 21.3% 12.5% 5.7% 4.2% 3.8% 4.1% 7.6% 6.1% 6.09%
Revenue 5Y 3.3% 3.7% 7.5% 6.9% 7.8% 7.8% 6.5% 8.8% 10.3% 15.1% 20.6% 21.5% 19.1% 16.0% 11.1% 11.1% 13.6% 14.2% 15.2% 11.6% 11.64%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 10.1% 22.9% 32.9% 37.9% 38.2% 30.3% 12.4% 6.5% 9.0% 12.3% 17.5% 12.6% -0.4% -11.7% -14.1% -25.7% -18.9% -14.1% -2.7% 10.0% 9.95%
Gross Profit 5Y -3.2% -2.0% 5.9% 6.6% 8.8% 10.7% 7.2% 6.2% 5.4% 10.9% 16.0% 18.8% 13.6% 6.1% 1.5% -7.8% -0.3% 2.4% 6.7% 9.3% 9.29%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 42.2% 42.2% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 61.6% 61.6% 61.6% 61.6% -14.4% -14.4% -14.4% -14.4% -23.7% -23.7% -23.73%
Assets 5Y 25.9% 25.9% 70.8% 70.8% 70.8% 70.8% 65.1% 65.1% 65.1% 65.1% 59.3% 59.3% 59.3% 59.3% 53.5% 53.5% 53.5% 53.5% 13.6% 13.6% 13.63%
Equity 3Y 57.4% 57.4% 90.7% 90.7% 90.7% 90.7% 1.2% 1.2% 1.2% 1.2% 27.9% 27.9% 27.9% 27.9% -13.8% -13.8% -13.8% -13.8% -78.8% -78.8% -78.82%
Book Value 3Y 37.3% 34.8% 67.4% 67.7% 67.7% 67.7% 90.7% 87.6% 84.9% 88.6% 16.8% 14.7% 15.1% 18.1% -22.8% -21.7% -21.8% -21.7% -80.8% -80.4% -80.41%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.09 0.05 0.26 0.31 0.40 0.47 0.44 0.70 0.76 0.82 0.77 0.85 0.95 0.97 0.63 0.63 0.75 0.72 0.54 0.48 0.477
Earnings Stability 0.05 0.13 0.01 0.15 0.25 0.20 0.33 0.51 0.59 0.50 0.58 0.72 0.81 0.73 0.72 0.85 0.98 0.92 0.85 0.20 0.197
Margin Stability 0.75 0.76 0.84 0.85 0.85 0.88 0.92 0.89 0.85 0.82 0.80 0.79 0.74 0.71 0.74 0.65 0.68 0.67 0.76 0.68 0.684
Rev. Growth Consistency 1.00 0.50 0.50 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.92 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.99 0.99 0.97 0.90 0.89 1.00 0.50 0.87 0.89 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.72 0.81 0.49 0.35 0.32 0.09 -0.49 -0.37 -0.32 -0.30 -0.04 -0.03 -0.16 -0.10 -0.11 -0.80 -0.47 -0.44 -101.62 -23.18 -23.177
Gross Margin Trend 0.07 0.06 0.05 0.03 0.03 0.01 -0.05 -0.10 -0.14 -0.16 -0.15 -0.12 -0.14 -0.15 -0.08 -0.14 -0.06 -0.00 0.03 0.15 0.155
FCF Margin Trend -0.29 -0.39 -0.57 -0.99 -1.34 -1.51 -1.85 -1.12 -0.78 -0.35 0.17 0.48 0.38 0.35 0.40 0.54 0.65 0.67 0.63 0.51 0.514
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.92 2.54 0.61 0.95 1.03 0.78 0.84 0.87 0.84 0.87 0.87 0.83 0.63 0.59 0.67 0.27 0.28 0.24 0.20 0.87 0.870
FCF/OCF 1.04 1.03 1.05 1.05 1.05 1.06 1.06 1.06 1.06 1.04 1.03 1.04 1.03 1.03 1.03 1.05 1.05 1.07 1.07 1.04 1.039
FCF/Net Income snapshot only 0.904
CapEx/Revenue 2.4% 2.6% 4.5% 6.8% 8.3% 10.7% 13.2% 12.7% 10.4% 7.0% 4.4% 4.5% 4.3% 3.8% 4.0% 5.7% 5.0% 5.5% 4.8% 2.7% 2.73%
CapEx/Depreciation snapshot only 0.486
Accruals Ratio -0.02 0.20 -0.06 -0.01 0.01 -0.05 -0.03 -0.02 -0.03 -0.02 -0.02 -0.03 -0.08 -0.09 -0.07 -0.32 -0.25 -0.25 -0.43 -0.02 -0.016
Sloan Accruals snapshot only -0.115
Cash Flow Adequacy snapshot only -25.605
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -3.3% -7.6% -7.2% -15.2% -30.9% -0.8% -0.5% -6.9% -5.9% -9.2% -7.5% -1.5% -3.3% -1.9% -1.4% -0.8% -0.7% -0.9% -0.6% -0.7% -0.72%
Total Shareholder Return -3.3% -7.6% -7.2% -15.2% -30.9% -0.8% -0.5% -6.9% -5.9% -9.2% -7.5% -1.5% -3.3% -1.9% -1.4% -0.8% -0.7% -0.9% -0.6% -0.7% -0.72%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 0.28 0.66 0.65 0.69 1.00 1.00 1.00 1.00 0.97 0.96 0.96 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.006
Interest Burden (EBT/EBIT) 1.07 1.07 1.05 1.06 1.05 1.05 1.05 1.05 1.05 1.05 1.05 1.05 1.04 1.04 1.05 1.02 1.02 1.01 1.01 0.82 0.823
EBIT Margin -0.68 -1.01 -2.01 -1.89 -2.04 -2.07 -2.33 -2.28 -2.08 -1.80 -1.52 -1.47 -2.10 -2.20 -1.92 -4.24 -3.31 -3.22 -3.39 -0.97 -0.971
Asset Turnover 0.38 0.43 0.11 0.11 0.12 0.11 0.07 0.07 0.08 0.09 0.11 0.11 0.11 0.10 0.10 0.10 0.10 0.10 0.16 0.16 0.157
Equity Multiplier 1.44 1.44 2.15 2.15 2.15 2.15 2.79 2.79 2.79 2.79 2.78 2.78 2.78 2.78 2.49 2.49 2.49 2.49 3.99 3.99 3.994
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.39 $-0.17 $-0.82 $-0.79 $-0.92 $-1.33 $-1.39 $-1.33 $-1.28 $-1.21 $-1.15 $-1.10 $-1.47 $-1.44 $-1.01 $-2.22 $-1.75 $-1.67 $-1.81 $-0.42 $-0.42
Book Value/Share $1.69 $1.56 $3.58 $3.56 $3.52 $3.51 $2.49 $2.33 $2.25 $2.21 $2.63 $2.60 $2.57 $2.57 $1.65 $1.71 $1.69 $1.68 $0.02 $0.02 $0.01
Tangible Book/Share $1.69 $1.56 $-0.14 $-0.13 $-0.13 $-0.13 $-1.14 $-1.06 $-1.03 $-1.01 $-0.82 $-0.81 $-0.80 $-0.80 $-0.65 $-0.68 $-0.67 $-0.67 $-1.08 $-1.07 $-1.07
Revenue/Share $0.53 $0.57 $0.59 $0.61 $0.62 $0.61 $0.57 $0.55 $0.58 $0.66 $0.75 $0.74 $0.69 $0.63 $0.50 $0.51 $0.52 $0.51 $0.53 $0.52 $0.52
FCF/Share $-0.37 $-0.45 $-0.53 $-0.79 $-1.00 $-1.11 $-1.24 $-1.22 $-1.13 $-1.10 $-1.03 $-0.95 $-0.96 $-0.88 $-0.69 $-0.62 $-0.52 $-0.44 $-0.39 $-0.38 $-0.38
OCF/Share $-0.36 $-0.44 $-0.50 $-0.75 $-0.94 $-1.04 $-1.16 $-1.15 $-1.07 $-1.05 $-1.00 $-0.92 $-0.93 $-0.85 $-0.67 $-0.59 $-0.50 $-0.41 $-0.37 $-0.37 $-0.37
Cash/Share $1.61 $1.48 $4.73 $4.70 $4.65 $4.64 $3.41 $3.19 $3.09 $3.03 $2.36 $2.34 $2.32 $2.31 $1.27 $1.31 $1.30 $1.30 $0.93 $0.91 $0.90
EBITDA/Share $-0.31 $-0.53 $-1.14 $-1.09 $-1.20 $-1.19 $-1.25 $-1.19 $-1.14 $-1.12 $-1.01 $-0.94 $-1.28 $-1.17 $-0.79 $-0.78 $-0.37 $-0.35 $-0.53 $-0.48 $-0.48
Debt/Share $0.21 $0.20 $4.33 $4.30 $4.26 $4.24 $4.19 $3.92 $3.79 $3.72 $3.50 $3.46 $3.43 $3.42 $2.19 $2.27 $2.24 $2.24 $2.52 $2.48 $2.48
Net Debt/Share $-1.39 $-1.29 $-0.40 $-0.40 $-0.40 $-0.40 $0.78 $0.73 $0.70 $0.69 $1.13 $1.12 $1.11 $1.11 $0.92 $0.95 $0.94 $0.94 $1.59 $1.57 $1.57
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -4.460
Altman Z-Prime snapshot only -9.311
Piotroski F-Score 5 4 4 3 4 3 2 2 2 2 4 5 3 3 2 1 2 3 4 4 4
Beneish M-Score -2.35 -1.65 16.88 17.14 17.16 17.10 -2.12 -2.34 -2.44 -2.22 -1.44 -1.77 -1.10 -1.45 -3.40 -9.30 -4.46 -4.37 -5.25 -3.15 -3.153
Ohlson O-Score snapshot only -3.654
Net-Net WC snapshot only $-1.32
EVA snapshot only $-177127490.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 60.43 60.34 35.76 32.30 26.89 33.19 26.97 32.08 32.41 27.14 34.46 28.33 28.19 27.67 28.22 28.12 28.03 27.69 22.01 21.65 21.650
Credit Grade snapshot only 16
Credit Trend snapshot only -6.468
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 8
Sector Credit Rank snapshot only 10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms